These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3074131)

  • 1. Laboratory studies on the mode of action and application of antiestrogen for breast cancer therapy.
    Jordan VC
    Int J Biol Markers; 1988; 3(1):53-4. PubMed ID: 3074131
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiestrogen receptors. What is their purpose?].
    Levin E; Schuarzberg P
    Medicina (B Aires); 1990; 50(1):74-80. PubMed ID: 2292917
    [No Abstract]   [Full Text] [Related]  

  • 3. Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer.
    Jordan VC
    Breast Cancer Res Treat; 1995; 36(3):267-85. PubMed ID: 8573710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. William L. McGuire Memorial Symposium. Drug resistance to tamoxifen during breast cancer therapy.
    Wolf DM; Jordan VC
    Breast Cancer Res Treat; 1993; 27(1-2):27-40. PubMed ID: 7505127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tamoxifen: modern drug therapy of estrogen-dependent breast tumors].
    Jovanović-Mićić D; Beleslin DB; Nikolić SS
    Med Pregl; 1996; 49(7-8):287-90. PubMed ID: 8926945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of antiestrogen action in breast cancer.
    Jordan VC
    Breast Cancer Res Treat; 1994; 31(1):41-52. PubMed ID: 7981455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiestrogen resistance: mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy.
    Katzenellenbogen BS
    J Natl Cancer Inst; 1991 Oct; 83(20):1434-5. PubMed ID: 1920488
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormone therapy for breast cancer, with an emphasis on the pure antiestrogen fulvestrant: mode of action, antitumor efficacy and effects on bone health.
    Journé F; Body JJ; Leclercq G; Laurent G
    Expert Opin Drug Saf; 2008 May; 7(3):241-58. PubMed ID: 18462183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oestrogen receptor and its selective modulators in gynaecological and breast cancer.
    Vergote I; Neven P; van Dam P; Serreyn R; De Prins F; De Sutter P; Albertyn G
    Eur J Cancer; 2000 Sep; 36 Suppl 4():S1-9. PubMed ID: 11056296
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer.
    Kurokawa H; Arteaga CL
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4436s-4442s; discussion 4411s-4412s. PubMed ID: 11916237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antiestrogen therapy on human mammary carcinomas with different estrogen receptor contents.
    Westerberg H; Nordenskjold B; Wrange O; Gustafsson JA; Humla S; Theve NO; Silfverswärd C; Granberg PO
    Eur J Cancer (1965); 1978 Jun; 14(6):619-22. PubMed ID: 658084
    [No Abstract]   [Full Text] [Related]  

  • 12. Tamoxifen (antiestrogen) therapy in advanced breast cancer.
    Kiang DT; Kennedy BJ
    Ann Intern Med; 1977 Dec; 87(6):687-90. PubMed ID: 931204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiestrogen treatment of breast cancer: an overview.
    Pearson OH; Manni A; Arafah BM
    Cancer Res; 1982 Aug; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental study on the determination of estrogen receptor and the effect of antiestrogen therapy in breast cancer].
    Imamura H
    Nihon Geka Gakkai Zasshi; 1991 Oct; 92(10):1493-502. PubMed ID: 1961187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo prediction of response to antiestrogen treatment in estrogen receptor-positive breast cancer.
    Bennink RJ; van Tienhoven G; Rijks LJ; Noorduyn AL; Janssen AG; Sloof GW
    J Nucl Med; 2004 Jan; 45(1):1-7. PubMed ID: 14734659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding endocrine resistance: the critical need for sequential samples from clinical breast cancer and novel in vitro models.
    Gee JM; Hutcheson IR
    Breast Cancer Res; 2005; 7(5):187-9. PubMed ID: 16168136
    [No Abstract]   [Full Text] [Related]  

  • 17. Tamoxifen resistance in breast cancer: elucidating mechanisms.
    Dorssers LC; Van der Flier S; Brinkman A; van Agthoven T; Veldscholte J; Berns EM; Klijn JG; Beex LV; Foekens JA
    Drugs; 2001; 61(12):1721-33. PubMed ID: 11693462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiestrogens--tamoxifen, SERMs and beyond.
    Dhingra K
    Invest New Drugs; 1999; 17(3):285-311. PubMed ID: 10665480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen, raloxifene, and the prevention of breast cancer.
    Jordan VC; Morrow M
    Endocr Rev; 1999 Jun; 20(3):253-78. PubMed ID: 10368771
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiestrogen-estrogen receptor interactions.
    Parker MG
    Cancer Treat Res; 1996; 83():213-24. PubMed ID: 8826649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.